Support PenkeMilestone Pharmaceuticals Inc - Trending symbols
Latest News of Milestone Pharmaceuticals Inc
| Date | Title | Read |
|---|---|---|
| 2025-07-11 20:50 | Milestone Pharmaceuticals Launches Public Offering To Support Etripamil Development | Read |
| 2025-07-11 12:01 | Milestone Pharmaceuticals Announces Proposed Public Offering | Read |
| 2025-07-11 12:00 | Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray | Read |
| 2025-06-16 14:36 | Milestone Pharma Announces Submission Of Its Response To CRL Regarding NDA For CARDAMYST | Read |
| 2025-06-16 14:09 | Milestone Pharmaceuticals submits response to FDA for PSVT drug | Read |
Trends
| 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Stockholder Equity | 39,921 | -7,943 | 31,978 | -7,966 | 24,012 | -10,865 | 13,147 | -19,270 | -6,123 | |
| Interest Expense | 872 | 15 | 887 | 16 | 903 | 16 | 919 | -1,854 | -935 | |
| Net Interest Income | 189 | -67 | 122 | 177 | 299 | -122 | 177 | -192 | -15 | |
| Total Other Income Expense Net | 189 | -67 | 122 | 177 | 299 | -122 | 177 | -257 | -80 | |
| Accumulated Other Comprehensive Income | -1,634 | 0 | -1,634 | 0 | -1,634 | 0 | -1,634 | 35,986 | 34,352 | |
| Net Debt | -62,684 | 27,977 | -34,707 | 29,562 | -5,145 | -19,119 | -24,264 | 41,997 | 17,733 | |
| Income Tax Expense | -158 | -316 | -474 | -30,961 | -31,435 | 30,883 | -552 | 1,765 | 1,213 | |
| Net Income | -16,918 | 2,951 | -13,967 | -2,523 | -16,490 | 2,408 | -14,082 | 32,340 | 18,258 | |
| Depreciation and Amortization | 23 | 0 | 23 | 1 | 24 | 3 | 27 | -62 | -35 |
Comments
How you think about this?